Advertisement

What do we know about brain contrast enhancement patterns in neuromyelitis optica?

      Abstract

      Neuromyelitis optica (NMO) is an autoimmune disorder of the central nervous system that usually presents with acute myelitis and/or optic neuritis. Recently, some brain magnetic resonance imaging findings have been described in NMO that are important in the differential diagnosis. Pencil-thin, leptomeningeal, and cloud-like enhancement may be specific to NMO. These patterns are usually seen during relapses. Recognizing these lesions and enhancement patterns may expedite the diagnosis and allows early effective treatment. The purpose of this article is to review the latest knowledge and to share our experience with the contrast enhancement patterns of NMO brain lesions.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lennon VA
        • Wingerchuk DM
        • Kryzer TJ
        • Pittock SJ
        • Lucchinetti CF
        • Fujihara K
        • et al.
        A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
        Lancet. 2004; 364: 2106-2112
        • Trebst C
        • Jarius S
        • Berthele A
        • Paul F
        • Schippling S
        • Wildemann B
        • et al.
        Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).
        J Neurol. 2014; 261: 1-16
        • Downer JJ
        • Leite MI
        • Carter R
        • Palace J
        • Küker W
        • Quaghebeur G
        Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?.
        Neuroradiology. 2012; 54: 279-285
        • Palace J
        • Leite M
        • Nairne A
        • Vincent A
        Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
        Arch Neurol. 2010; 67: 1016-1017
        • Juryńczyk M
        • Zaleski K
        • Selmaj K
        Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
        J Neurol. 2013; 260: 1919-1921
        • Tackley G
        • Kuker W
        • Palace J
        Magnetic resonance imaging in neuromyelitis optica.
        Mult Scler. 2014; ([pii: 1352458514531087]): 14
        • Wingerchuk DM
        • Lennon VA
        • Pittock SJ
        • Lucchinetti CF
        • Weinshenker BG
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489
        • Pittock SJ
        • Lennon VA
        • Krecke K
        • Wingerchuk DM
        • Lucchinetti CF
        • Weinshenker BG
        Brain abnormalities in neuromyelitis optica.
        Arch Neurol. 2006; 63: 390-396
        • Wingerchuk DM
        • Hogancamp WF
        • O'Brien PC
        • Weinshenker BG
        The clinical course of neuromyelitis optica (Devic's syndrome).
        Neurology. 1999; 53: 1107-1114
        • Makhani N
        • Bigi S
        • Banwell B
        • Shroff M
        Diagnosing neuromyelitis optica.
        Neuroimaging Clin N Am. 2013; 23: 279-291
        • Wang F
        • Liu Y
        • Duan Y
        • Li K
        Brain MRI abnormalities in neuromyelitis optica.
        Eur J Radiol. 2011; 80: 445-449
        • Cabrera-Gomez JA
        • Kister I
        Conventional brain MRI in neuromyelitis optica.
        Eur J Neurol. 2012; 19: 812-819
        • Matthews L
        • Marasco R
        • Jenkinson M
        • Küker W
        • Luppe S
        • Leite MI
        • et al.
        Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
        Neurology. 2013; 80: 1330-1337
        • Chen Z
        • Feng F
        • Yang Y
        • Li J
        • Ma L
        MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
        Eur J Radiol. 2012; 81: 3491-3495
        • Popescu BF
        • Lennon VA
        • Parisi JE
        • Howe CL
        • Weigand SD
        • Cabrera-Gómez JA
        • et al.
        Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.
        Neurology. 2011; 76: 1229-1237
        • Apiwattanakul M
        • Popescu BF
        • Matiello M
        • Weinshenker BG
        • Lucchinetti CF
        • Lennon VA
        • et al.
        Intractable vomiting as the initial presentation of neuromyelitis optica.
        Ann Neurol. 2010; 68: 757-761
        • Baba T
        • Nakashima I
        • Kanbayashi T
        • Konno M
        • Takahashi T
        • Fujihara K
        • et al.
        Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.
        J Neurol. 2009; 256: 287-288
        • McKeon A
        • Lennon VA
        • Lotze T
        • Tenenbaum S
        • Ness JM
        • Rensel M
        • et al.
        CNS aquaporin-4 autoimmunity in children.
        Neurology. 2008; 71: 93-100
        • Choi SI
        • Lee YJ
        • Kim do W
        • Yang JY
        A case of neuromyelitis optica misdiagnosed as cervicogenic headache.
        Korean J Pain. 2014; 27: 77-80
        • Eichel R
        • Meiner Z
        • Abramsky O
        • Gotkine M
        Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
        Arch Neurol. 2008; 65: 267-271
        • Ito S
        • Mori M
        • Makino T
        • Hayakawa S
        • Kuwabara S
        "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
        Ann Neurol. 2009; 66: 425-428
        • Matsushita T
        • Isobe N
        • Matsuoka T
        • Ishizu T
        • Kawano Y
        • Yoshiura T
        • et al.
        Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions.
        Mult Scler. 2009; 15: 1113-1117
        • Magaña SM
        • Matiello M
        • Pittock SJ
        • McKeon A
        • Lennon VA
        • Rabinstein AA
        • et al.
        Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
        Neurology. 2009; 72: 712-717
        • Kim W
        • Park MS
        • Lee SH
        • Kim SH
        • Jung IJ
        • Takahashi T
        • et al.
        Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.
        Mult Scler. 2010; 16: 1229-1236
        • Kim JE
        • Kim SM
        • Ahn SW
        • Lim BC
        • Chae JH
        • Hong YH
        • et al.
        Brain abnormalities in neuromyelitis optica.
        J Neurol Sci. 2011; 302: 43-48
        • Kim W
        • Kim SH
        • Lee SH
        • Li XF
        • Kim HJ
        Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.
        Mult Scler. 2011; 17: 1107-1112
        • Newey CR
        • Bermel RA
        Fulminant cerebral demyelination in neuromyelitis optica.
        Neurology. 2011; 77: 193
        • Tahara M
        • Ito R
        • Tanaka K
        • Tanaka M
        Cortical and leptomeningeal involvement in three cases of neuromyelitis optica.
        Eur J Neurol. 2012; 19: e47-e48
        • McGraw CA
        • Swerdlow ML
        • Robbins MS
        Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
        Eur J Neurol. 2012; 19: e57-e58
        • Banker P
        • Sonni S
        • Kister I
        • Loh JP
        • Lui YW
        Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders.
        Mult Scler. 2012; 18: 1050-1053
        • Cheng C
        • Jiang Y
        • Chen X
        • Dai Y
        • Kang Z
        • Lu Z
        • et al.
        Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
        BMC Neurol. 2013; 13: 72
        • Iorio R
        • Damato V
        • Mirabella M
        • Evoli A
        • Marti A
        • Plantone D
        • et al.
        Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
        J Neurol. 2013; 260: 2396-2402
        • Huh SY
        • Min JH
        • Kim W
        • Kim SH
        • Kim HJ
        • Kim BJ
        • et al.
        The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
        Mult Scler. 2014; 20: 695-704
        • Long Y
        • Chen M
        • Zhang B
        • Gao C
        • Zheng Y
        • Xie L
        • et al.
        Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
        J Neuroimmunol. 2014; 269: 62-67
        • Pekcevik Y
        • Izbudak I
        Perivascular enhancement in a patient with neuromyelitis optica spectrum disease during an optic neuritis attack.
        J Neuroimaging. 2014; https://doi.org/10.1111/jon.12198
        • Levy LM
        Exceeding the limits of the normal blood–brain barrier: quo vadis gadolinium?.
        AJNR Am J Neuroradiol. 2007; 28: 1835-1836
        • Misu T
        • Fujihara K
        • Kakita A
        • Konno H
        • Nakamura M
        • Watanabe S
        • et al.
        Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
        Brain. 2007; 130: 1224-1234
        • Lucchinetti CF
        • Mandler RN
        • McGavern D
        • Bruck W
        • Gleich G
        • Ransohoff RM
        • et al.
        A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
        Brain. 2002; 125: 1450-1461
        • Lennon VA
        • Kryzer TJ
        • Pittock SJ
        • Verkman AS
        • Hinson SR
        IgG marker of optic–spinal multiple sclerosis binds to the aquaporin-4 water channel.
        J Exp Med. 2005; 202: 473-477
        • Pittock SJ
        • Weinshenker BG
        • Lucchinetti CF
        • Wingerchuk DM
        • Corboy JR
        • Lennon VA
        Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
        Arch Neurol. 2006; 63: 964-968
        • Zhang L
        • Wu A
        • Zhang B
        • Chen S
        • Men X
        • Lin Y
        • et al.
        Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
        Mult Scler. 2014; 20: 418-423
        • Khanna S.
        • Sharma A.
        • Huecker J.
        • Gordon M.
        • Naismith R.T.
        • Van Stavern G.P.
        Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis.
        J Neuroophthalmol. 2012; 32: 216-220